Post Archive by Month

Despite the uncertainties in global macroeconomic activities, the top 20 global biopharmaceutical companies experienced a promising first quarter in 2024.
GlobalData recently reported that these companies' market capitalizations increased by 9.6% to reach $4 trillion.
As of March 31, 2024, seven companies reported positive growth in market capitalization, led by Lilly (33.7%), Novo Nordisk (23.8%), and Merck & Co (21%).

The current incidence of the Zika virus (ZIKV) is low globally; it has not disappeared. Significant outbreaks are continuing in 2024, especially in countries such as Brazil.
Unfortunately, no approved Zika vaccines are available.

Since the early days of AOL and Yahoo, digital information has transformed how people access and share health information. While the digital age has increased access, it has also accelerated the spread of disinformation and misinformation.
To address this issue, Dr. C. Everett Koop spearheaded an industry initiative in 1999 to protect people from unreliable health information by involving doctors, nurses, and pharmacists in the content creation.

The global gene editing market is forecast to reach around $29 billion by 2032, with the goal of targeting underserved diseases, such as herpes simplex virus (HSV).
Researchers recently announced that they found an experimental gene therapy for genital and oral HSV that removed 90% or more of the infection.
They developed a potentially curative approach against HSV infection based on gene editing using HSV-specific meganucleases delivered by adeno-associated virus (AAV) vectors.

The World Health Organization (WHO) Africa recently confirmed that the African country of Angola had been free of wild poliovirus since July 2011 and declared the interruption of polio transmission in November 2015.
Unfortunately, Angola recently reported a concerning development in early 2024.
Four cases of Poliovirus Type 2 have been detected in environmental samples of sewage water collected in two provinces. Additionally, two cases of Acute Flaccid Paralysis (AFP) have been reported in early May 2024.

A recent study suggests that providing vaccinations at school can effectively reduce preventable cancers. School-based vaccination programs have successfully demonstrated value in reducing influenza and meningitis.
In a cluster randomized PrevHPV clinical trial involving 91 municipalities, it was found that offering free human papillomavirus (HPV) vaccinations to students on school premises consistently and significantly increased vaccination coverage.

The Government of Djibouti has made a historic move in the fight against malaria by launching the first pilot releases of Oxitec's Friendly™ mosquitoes on African soil.
According to Oxitec, this marks a significant milestone for the Djibouti Friendly™ Mosquito Program, a public-private partnership.
This initiative aims to control the Anopheles stephensi mosquito, which is responsible for the significant increase in urban malaria cases in Djibouti's capital city, which has a population of over 1 million and is located in the Horn of Africa.

The Government of Djibouti has made a historic move in the fight against malaria by launching the first pilot releases of Oxitec's Friendly™ mosquitoes on African soil.
According to Oxitec, this marks a significant milestone for the Djibouti Friendly™ Mosquito Program, a public-private partnership.
This initiative aims to control the Anopheles stephensi mosquito, which is responsible for the significant increase in urban malaria cases in Djibouti's capital city, which has a population of over 1 million and is located in the Horn of Africa.